The purpose of this study is to investigate the pharmacokinetics of levodopa, carbidopa,
3-OMD and ODM-104 after repeated doses of 3 levodopa formulations given in combination with
carbidopa and ODM-104.
Phase:
Phase 1
Details
Lead Sponsor:
Orion Corporation, Orion Pharma
Treatments:
Carbidopa Carbidopa, levodopa drug combination Levodopa